Background illustration for clinical trials search

Paid Clinical Trials Costa Mesa

Discover 3,561 paid clinical trials in Costa Mesa, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

for
Acute Myeloid Leukemias
Location: Duarte CA, Goodyear AZ, Shreveport LA, Toronto,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 12+

Code: NCT07211958

Phase3, Recruiting

Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

for
Radiation Therapy
Location: Duarte CA, Los Angeles CA
Sponsor: DxTerity Diagnostics

Sex: All

Age: 18+

Code: NCT03142425

Recruiting

Study EHR Risk Stratification Tools

for
Prediabetes, Health Communication, Patient Comprehension
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 65+

Code: NCT06995378

Recruiting

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

for
Lipoprotein(a)
Location: Beverly Hills CA, Lincoln CA, Albuquerque NM,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07614984

Phase2, Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, San Francisco CA, Denver CO, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT04485559

Phase1, Recruiting

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05263284

Phase1, Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Duarte CA, Sacramento CA, Seattle WA, Oklahoma City OK,
Sponsor: Ansun Biopharma, Inc.

Sex: All

Age: 0+

Code: NCT03808922

Phase3, Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Duarte CA, Las Vegas NV, West Valley City UT,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase1, Recruiting

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

for
HER2-negative Breast Cancer Patients With Brain Metastases
Location: Duarte CA, Los Angeles CA, San Diego CA, Las Vegas NV,
Sponsor: Biostar Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06764940

Phase2, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

for
Muscle Invasive Bladder Urothelial Carcinoma
Location: Duarte CA, Indianapolis IN, Philadelphia PA,
Sponsor: Matthew Galsky

Sex: All

Age: 18+

Code: NCT06809140

Phase2, Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Duarte CA, Denver CO, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase1, Phase2, Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

for
Stroke, TIA, Ischemic Stroke, Ischemic
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 30+

Code: NCT05518305

Recruiting

Polyphenols and Cognitive Decline

for
Cognitive Decline, Cognitive Dysfunction
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 50+

Code: NCT06507254

Recruiting

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

for
MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML
Location: Duarte CA, Stanford CA, Salt Lake City UT, Portland OR,
Sponsor: Jasper Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04429191

Phase1, Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,
Location: Duarte CA, Las Vegas NV, Houston TX, Milwaukee WI,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05967689

Phase2, Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Duarte CA, Phoenix AZ, Rochester MN, Tampa FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06090539

Phase1, Phase2, Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Duarte CA, Aurora CO, Seattle WA, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase1, Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Torrance CA, Stockton CA, Salem OR, Tacoma WA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting